222. 一次性ネフローゼ症候群 Primary nephrotic syndrome Clinical trials / Disease details

臨床試験数 : 285 / 薬物数 : 285 - (DrugBank : 108) / 標的遺伝子数 : 62 - 標的パスウェイ数 : 191

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005855-19-ES (EUCTR)	11/10/2021	05/08/2021	Evaluating oral BCX9930 in renal diseases	An Open-Label, Safety, Tolerability, and Proof-of-Concept Study of Oral BCX9930 Therapy in Subjects ...	complement 3 glomerulopathyimmunoglobulin A nephropathyprimary membranous nephropathy MedDRA version ...	Product Name: BCX9930 Product Code: BCX9930 INN or Proposed INN: BCX9930 Other descriptive name: BCX993 ...	BioCryst Pharmaceuticals Inc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	42	Phase 2	France;Spain;Germany;United Kingdom;Italy
2	EUCTR2020-005855-19-IT (EUCTR)	01/10/2021	22/10/2021	Evaluating oral BCX9930 in renal diseases	An Open-Label, Safety, Tolerability, and Proof-of-Concept Study of Oral BCX9930 Therapy in Subjects ...	complement 3 glomerulopathyimmunoglobulin A nephropathyprimary membranous nephropathy MedDRA version ...	Product Name: BCX9930 Product Code: [BCX9930] INN or Proposed INN: BCX9930 Other descriptive name: BCX9 ...	BIOCRYST PHARMACEUTICALS INC.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	42	Phase 2	France;Spain;Germany;United Kingdom;Italy

First Previous1Next Last